YU88801A - Indalinom supstituisan benzolkarbonamid, postupak za njegovu proizvodnju, njegova prrimena kao medikamenata kao i farmaceutski preparati koji ga sadrže - Google Patents
Indalinom supstituisan benzolkarbonamid, postupak za njegovu proizvodnju, njegova prrimena kao medikamenata kao i farmaceutski preparati koji ga sadržeInfo
- Publication number
- YU88801A YU88801A YU88801A YUP88801A YU88801A YU 88801 A YU88801 A YU 88801A YU 88801 A YU88801 A YU 88801A YU P88801 A YUP88801 A YU P88801A YU 88801 A YU88801 A YU 88801A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- same
- pharmaaceutical
- mathod
- carbonamide
- indanyl
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 206010003662 Atrial flutter Diseases 0.000 abstract 4
- 229910052700 potassium Inorganic materials 0.000 abstract 2
- 239000011591 potassium Substances 0.000 abstract 2
- 206010003130 Arrhythmia supraventricular Diseases 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 210000002837 heart atrium Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
- C07C311/26—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19929076A DE19929076A1 (de) | 1999-06-25 | 1999-06-25 | Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU88801A true YU88801A (sh) | 2004-09-03 |
Family
ID=7912468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU88801A YU88801A (sh) | 1999-06-25 | 2000-06-10 | Indalinom supstituisan benzolkarbonamid, postupak za njegovu proizvodnju, njegova prrimena kao medikamenata kao i farmaceutski preparati koji ga sadrže |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6221866B1 (enExample) |
| EP (1) | EP1194403B1 (enExample) |
| JP (1) | JP4527918B2 (enExample) |
| KR (1) | KR20020023962A (enExample) |
| CN (1) | CN1157372C (enExample) |
| AR (1) | AR024443A1 (enExample) |
| AT (1) | ATE248811T1 (enExample) |
| AU (1) | AU771601B2 (enExample) |
| BR (1) | BR0011938A (enExample) |
| CA (1) | CA2377087A1 (enExample) |
| CZ (1) | CZ20014523A3 (enExample) |
| DE (2) | DE19929076A1 (enExample) |
| DK (1) | DK1194403T3 (enExample) |
| EE (1) | EE04464B1 (enExample) |
| ES (1) | ES2200886T3 (enExample) |
| HK (1) | HK1047575B (enExample) |
| HU (1) | HUP0201711A3 (enExample) |
| IL (1) | IL147220A0 (enExample) |
| MX (1) | MXPA01012281A (enExample) |
| NO (1) | NO20015816D0 (enExample) |
| NZ (1) | NZ516347A (enExample) |
| PL (1) | PL352985A1 (enExample) |
| PT (1) | PT1194403E (enExample) |
| RU (1) | RU2238934C2 (enExample) |
| SI (1) | SI1194403T1 (enExample) |
| SK (1) | SK19092001A3 (enExample) |
| TR (1) | TR200103701T2 (enExample) |
| TW (1) | TWI256950B (enExample) |
| WO (1) | WO2001000573A1 (enExample) |
| YU (1) | YU88801A (enExample) |
| ZA (1) | ZA200109732B (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6970362B1 (en) | 2000-07-31 | 2005-11-29 | Intel Corporation | Electronic assemblies and systems comprising interposer with embedded capacitors |
| US6775150B1 (en) | 2000-08-30 | 2004-08-10 | Intel Corporation | Electronic assembly comprising ceramic/organic hybrid substrate with embedded capacitors and methods of manufacture |
| JP2004509894A (ja) | 2000-09-20 | 2004-04-02 | ファルマシア・アンド・アップジョン・カンパニー | 置換アゼピノ［４，５−ｂ］インドリン誘導体 |
| DE10121003A1 (de) | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10121002A1 (de) * | 2001-04-28 | 2002-11-14 | Aventis Pharma Gmbh | Verwendung von Anthranilsäureamiden als Medikament zur Behandlung von Arrhythmien sowie sie enthaltende pharmazeutische Zubereitungen |
| US7119112B2 (en) * | 2002-02-28 | 2006-10-10 | Icagen, Inc. | Sulfonamides as potassium channel blockers |
| ATE524452T1 (de) | 2003-03-27 | 2011-09-15 | Cytokinetics Inc | Sulfonamide zur behandlung von kongestivem herzversagen, deren zusammensetzungen und verwendungen. |
| GB0315950D0 (en) | 2003-06-11 | 2003-08-13 | Xention Discovery Ltd | Compounds |
| US7368582B2 (en) | 2003-10-17 | 2008-05-06 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
| GB0412986D0 (en) | 2004-06-10 | 2004-07-14 | Xention Discovery Ltd | Compounds |
| US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
| US7576212B2 (en) | 2004-12-09 | 2009-08-18 | Xention Limited | Thieno[2,3-B] pyridines as potassium channel inhibitors |
| DE102005028845A1 (de) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
| WO2007023775A1 (ja) * | 2005-08-23 | 2007-03-01 | Astellas Pharma Inc. | 心房細動治療剤 |
| GB0525164D0 (en) | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
| SG163543A1 (en) * | 2006-04-27 | 2010-08-30 | Sanofi Aventis Deutschland | Inhibitors of the task-1 and task-3 ion channel |
| EP2081905B1 (en) | 2006-07-28 | 2012-09-12 | Boehringer Ingelheim International GmbH | Sulfonyl compounds which modulate the cb2 receptor |
| MX2009002888A (es) | 2006-09-25 | 2009-03-31 | Boehringer Ingelheim Int | Compuestos que modulan el receptor cb2. |
| WO2008098025A1 (en) * | 2007-02-08 | 2008-08-14 | Boehringer Ingelheim International Gmbh | Arylsulfonamide compounds which modulate the cb2 receptor |
| JP4891111B2 (ja) * | 2007-02-16 | 2012-03-07 | 富士フイルム株式会社 | ズームレンズ |
| CL2008000835A1 (es) | 2007-03-23 | 2008-10-03 | Icagen Inc Pfizer Ltd | Compuestos derivados de sulfonamidas, inhibidores de los canales de calcio; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor, sindrome de intestino irritable, enfermedad de crohn, taquiarritm |
| WO2009061652A1 (en) * | 2007-11-07 | 2009-05-14 | Boehringer Ingelheim International Gmbh | Compounds which modulate the cb2 receptor |
| EP2326629B1 (en) * | 2008-07-10 | 2013-10-02 | Boehringer Ingelheim International GmbH | Sulfone compounds which modulate the cb2 receptor |
| GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| NZ591111A (en) | 2008-09-25 | 2013-08-30 | Boehringer Ingelheim Int | Sulfonyl compounds which selectively modulate the cb2 receptor |
| US8299103B2 (en) * | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
| US8383615B2 (en) | 2009-06-16 | 2013-02-26 | Boehringer Ingelheim International Gmbh | Azetidine 2-carboxamide derivatives which modulate the CB2 receptor |
| EP2480544A1 (en) * | 2009-09-22 | 2012-08-01 | Boehringer Ingelheim International GmbH | Compounds which selectively modulate the cb2 receptor |
| EP2523936A1 (en) | 2010-01-15 | 2012-11-21 | Boehringer Ingelheim International GmbH | Compounds which modulate the cb2 receptor |
| WO2011109324A1 (en) | 2010-03-05 | 2011-09-09 | Boehringer Ingelheim International Gmbh | Tetrazole compounds which selectively modulate the cb2 receptor |
| JP5746764B2 (ja) | 2010-07-22 | 2015-07-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｂ２受容体を調節する化合物 |
| GB201105659D0 (en) | 2011-04-01 | 2011-05-18 | Xention Ltd | Compounds |
| NO3175985T3 (enExample) | 2011-07-01 | 2018-04-28 | ||
| AU2013203252B2 (en) | 2012-01-27 | 2015-08-20 | Gilead Sciences, Inc. | Combination therapies using late sodium ion channel blockers and potassium ion channel blockers |
| EP2803668A1 (en) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles |
| EP3366683A1 (en) | 2017-02-28 | 2018-08-29 | Acousia Therapeutics GmbH | Cyclic amides, acteamides and ureas useful as potassium channel openers |
| CN114206335B (zh) * | 2019-05-03 | 2025-03-11 | 普拉克西斯精密药物股份有限公司 | Kcnt1抑制剂和使用方法 |
| US11773088B2 (en) | 2020-11-02 | 2023-10-03 | Praxis Precision Medicines, Inc. | KCNT1 inhibitors and methods of use |
| WO2023211855A1 (en) * | 2022-04-25 | 2023-11-02 | Praxis Precision Medicines, Inc. | Kcnt1 inhibitors comprising a thiophene core and methods of use |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5234944A (en) | 1986-08-21 | 1993-08-10 | Roussel Uclaf | Novel indanes |
| EP0258096B1 (fr) * | 1986-08-21 | 1992-09-09 | Roussel-Uclaf | Dérivés de l'indane, leur procédé de préparation, leur application à titre de médicaments, les compositions pharmaceutiques les renfermant et les intermédiaires obtenus |
| DK626889A (da) | 1988-12-16 | 1990-06-17 | Roussel Uclaf | Indanderivater, deres fremstilling samt laegemidler med indhold deraf |
| US5348971A (en) | 1988-12-16 | 1994-09-20 | Roussel Uclaf | Indanes useful as analgesics |
| RU2043337C1 (ru) * | 1990-07-20 | 1995-09-10 | Институт биохимии Литовской АН | Способ получения 5-аргиниламинонафталин-1-сульфамидов |
| FR2708608B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant. |
| AU1867095A (en) * | 1994-01-10 | 1995-08-01 | Technion Research & Development Foundation Ltd. | 1-aminoindan derivatives and compositions thereof |
| US5914349A (en) | 1994-01-10 | 1999-06-22 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| US6083986A (en) * | 1996-07-26 | 2000-07-04 | Icagen, Inc. | Potassium channel inhibitors |
| DE19707656A1 (de) * | 1997-02-26 | 1998-08-27 | Hoechst Ag | Sulfonamid-substituierte anellierte 7-Ring-Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
| CN1273579A (zh) * | 1997-08-05 | 2000-11-15 | 美国家用产品公司 | 氨茴酸类似物 |
| DE19749453A1 (de) * | 1997-11-10 | 1999-05-12 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte anellierte 5-Ring-Verbindungen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
-
1999
- 1999-06-25 DE DE19929076A patent/DE19929076A1/de not_active Withdrawn
-
2000
- 2000-06-10 PL PL00352985A patent/PL352985A1/xx not_active Application Discontinuation
- 2000-06-10 MX MXPA01012281A patent/MXPA01012281A/es unknown
- 2000-06-10 DE DE50003555T patent/DE50003555D1/de not_active Expired - Lifetime
- 2000-06-10 WO PCT/EP2000/005370 patent/WO2001000573A1/de not_active Ceased
- 2000-06-10 DK DK00940359T patent/DK1194403T3/da active
- 2000-06-10 CZ CZ20014523A patent/CZ20014523A3/cs unknown
- 2000-06-10 BR BR0011938-5A patent/BR0011938A/pt not_active IP Right Cessation
- 2000-06-10 SK SK1909-2001A patent/SK19092001A3/sk unknown
- 2000-06-10 RU RU2002101723/04A patent/RU2238934C2/ru not_active IP Right Cessation
- 2000-06-10 ES ES00940359T patent/ES2200886T3/es not_active Expired - Lifetime
- 2000-06-10 HK HK02108652.0A patent/HK1047575B/zh not_active IP Right Cessation
- 2000-06-10 SI SI200030224T patent/SI1194403T1/xx unknown
- 2000-06-10 IL IL14722000A patent/IL147220A0/xx unknown
- 2000-06-10 CA CA002377087A patent/CA2377087A1/en not_active Abandoned
- 2000-06-10 TR TR2001/03701T patent/TR200103701T2/xx unknown
- 2000-06-10 HU HU0201711A patent/HUP0201711A3/hu unknown
- 2000-06-10 EP EP00940359A patent/EP1194403B1/de not_active Expired - Lifetime
- 2000-06-10 YU YU88801A patent/YU88801A/sh unknown
- 2000-06-10 NZ NZ516347A patent/NZ516347A/xx unknown
- 2000-06-10 JP JP2001506984A patent/JP4527918B2/ja not_active Expired - Fee Related
- 2000-06-10 EE EEP200100684A patent/EE04464B1/xx not_active IP Right Cessation
- 2000-06-10 KR KR1020017016458A patent/KR20020023962A/ko not_active Ceased
- 2000-06-10 PT PT00940359T patent/PT1194403E/pt unknown
- 2000-06-10 CN CNB008094500A patent/CN1157372C/zh not_active Expired - Fee Related
- 2000-06-10 AU AU55318/00A patent/AU771601B2/en not_active Ceased
- 2000-06-10 AT AT00940359T patent/ATE248811T1/de not_active IP Right Cessation
- 2000-06-22 AR ARP000103128A patent/AR024443A1/es unknown
- 2000-06-22 TW TW089112238A patent/TWI256950B/zh not_active IP Right Cessation
- 2000-06-23 US US09/603,436 patent/US6221866B1/en not_active Expired - Fee Related
-
2001
- 2001-11-27 ZA ZA200109732A patent/ZA200109732B/en unknown
- 2001-11-29 NO NO20015816A patent/NO20015816D0/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU88801A (sh) | Indalinom supstituisan benzolkarbonamid, postupak za njegovu proizvodnju, njegova prrimena kao medikamenata kao i farmaceutski preparati koji ga sadrže | |
| YU24402A (sh) | 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja | |
| PL365318A1 (en) | Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors | |
| MY138341A (en) | Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use | |
| AR031430A1 (es) | Compuestos de bisarilo orto, meta-sustituidos, procedimientos para su preparacion, su utilizacion como medicamento como tambien los preparados farmaceuticos que los contienen | |
| TNSN03084A1 (en) | Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof | |
| YU42503A (sh) | Arilovani furan-1 tiofen-amidi-karbonske kiseline sa blokirajućim dejstvom kalijumovog kanala | |
| BR0210791A (pt) | Composição tendo atividade bacteristática e bactericida contra esporos bacterianos e células vegetativas e processo para tratamento de alimentos utilizando a mesma | |
| BR0014804A (pt) | Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto | |
| ES2008865B3 (es) | Procedimiento para preparar una composicion antiseptica. | |
| BR9709427A (pt) | Oxa ácidos e compostos relacionados para tratamento de condições da pele | |
| HRP20060251A2 (en) | Substituted oxasolidinones and their use | |
| BR0316776A (pt) | Formula para anti-infeccioso tópico | |
| MD1688F2 (en) | Benzothiophene, benzofuran and indolethiazepinons, oxazepinons and diazepinons, pharmaceutical composition, method of inhibiting the leucocytes adherence to the endothelial cells for inflammatory diseases treatment and method of treatment of the mammals affected by the HIV infection | |
| CA2225903A1 (en) | Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use | |
| BR0206791A (pt) | Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto | |
| BR9914158A (pt) | Composição antibiótica para o tratamento dos olhos, ouvidos e nariz | |
| BR0016678A (pt) | Composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto | |
| IL188092A0 (en) | Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them | |
| YU5893A (sh) | Sulfonilkarbamid i postupak za njegovo dobijanje | |
| AU530678B2 (en) | Phosphono-hydroxy-acetic acid | |
| MX9704094A (es) | Benzoil-guanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. | |
| BR0312183A (pt) | Uso de compostos benzisosselenazolonas contra lesão miocárdica isquêmica | |
| AU4302996A (en) | Uracil derivatives | |
| MXPA05009763A (es) | 2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto. |